Jose Antonio Ramos

Summary

Affiliation: Universidad Complutense
Country: Spain

Publications

  1. ncbi request reprint Effects on development
    J A Ramos
    Departamento de Bioquimica, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain
    Handb Exp Pharmacol . 2005
  2. ncbi request reprint Exposure to cannabinoids in the development of endogenous cannabinoid system
    Jose A Ramos
    Instituto Universitario de Drogodependencias, Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain
    Neurotox Res 4:363-72. 2002
  3. ncbi request reprint Therapeutic potential of the endocannabinoid system in the brain
    Jose Antonio Ramos
    Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad Complutense, Madrid, Spain
    Mini Rev Med Chem 5:609-17. 2005
  4. ncbi request reprint UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders
    Eva de Lago
    Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain
    Eur Neuropsychopharmacol 16:7-18. 2006
  5. ncbi request reprint Effects of perinatal exposure to delta 9-tetrahydrocannabinol on operant morphine-reinforced behavior
    Begona Gonzalez
    Departamento de Psicobiologia, Facultad de Psicologia, Universidad Nacional de Educacion a Distancia, Ciudad Universitaria, 28040 Madrid, Spain
    Pharmacol Biochem Behav 75:577-84. 2003
  6. ncbi request reprint Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease
    Eva de Lago
    Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain
    Brain Res 1050:210-6. 2005
  7. ncbi request reprint Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity
    Henrik H Hansen
    Department of Biochemistry and Molecular Biology, Faculty of Medicine, Complutense University, Avenida de Complutense s n, 28040 Madrid, Spain
    J Neurochem 82:154-8. 2002
  8. ncbi request reprint Prenatal cannabinoid and gene expression for neural adhesion molecule L1 in the fetal rat brain
    Maria Gomez
    Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad Compultense de Madrid, Spain
    Brain Res Dev Brain Res 147:201-7. 2003
  9. ncbi request reprint Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis
    Ana Cabranes
    Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain
    Neurobiol Dis 20:207-17. 2005
  10. ncbi request reprint Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats
    Eva M Romero
    Departamento de Biologia Animal II, Facultad de Biologia, Universidad Complutense, 28040 Madrid, Spain
    Brain Res Dev Brain Res 136:85-92. 2002

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Effects on development
    J A Ramos
    Departamento de Bioquimica, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain
    Handb Exp Pharmacol . 2005
    ..Thus, endocannabinoids have been reported to be present in early ages and to play a role in the process of brain development: neural proliferation and migration, axonal elongation, synaptogenesis and/or myelogenesis...
  2. ncbi request reprint Exposure to cannabinoids in the development of endogenous cannabinoid system
    Jose A Ramos
    Instituto Universitario de Drogodependencias, Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain
    Neurotox Res 4:363-72. 2002
    ..The present review article will summarize the different studies carried out on this topic and will suggest future lines of research to clarify the role of endocannabinoids and their receptors in the development...
  3. ncbi request reprint Therapeutic potential of the endocannabinoid system in the brain
    Jose Antonio Ramos
    Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad Complutense, Madrid, Spain
    Mini Rev Med Chem 5:609-17. 2005
    ....
  4. ncbi request reprint UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders
    Eva de Lago
    Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain
    Eur Neuropsychopharmacol 16:7-18. 2006
    ....
  5. ncbi request reprint Effects of perinatal exposure to delta 9-tetrahydrocannabinol on operant morphine-reinforced behavior
    Begona Gonzalez
    Departamento de Psicobiologia, Facultad de Psicologia, Universidad Nacional de Educacion a Distancia, Ciudad Universitaria, 28040 Madrid, Spain
    Pharmacol Biochem Behav 75:577-84. 2003
    ....
  6. ncbi request reprint Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease
    Eva de Lago
    Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain
    Brain Res 1050:210-6. 2005
    ..Nevertheless, considering the lack of efficacious pharmacological treatments in this basal ganglia disorder, our findings might provide the basis for the development of more specific drugs against HD...
  7. ncbi request reprint Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity
    Henrik H Hansen
    Department of Biochemistry and Molecular Biology, Faculty of Medicine, Complutense University, Avenida de Complutense s n, 28040 Madrid, Spain
    J Neurochem 82:154-8. 2002
    ..These results suggest a critical involvement of CB(1) receptor tonus on neuronal survival following NMDA receptor-induced excitotoxicity in vivo...
  8. ncbi request reprint Prenatal cannabinoid and gene expression for neural adhesion molecule L1 in the fetal rat brain
    Maria Gomez
    Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad Compultense de Madrid, Spain
    Brain Res Dev Brain Res 147:201-7. 2003
    ....
  9. ncbi request reprint Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis
    Ana Cabranes
    Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain
    Neurobiol Dis 20:207-17. 2005
    ....
  10. ncbi request reprint Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats
    Eva M Romero
    Departamento de Biologia Animal II, Facultad de Biologia, Universidad Complutense, 28040 Madrid, Spain
    Brain Res Dev Brain Res 136:85-92. 2002
    ..The cannabinoid agonist (0.6 mg/kg) induced a CB(1)-mediated increase in the serum corticosterone levels, but no effect on the dopaminergic systems of either the striatum or the limbic forebrain was found...
  11. ncbi request reprint Down-regulation of the AMPA glutamate receptor subunits GluR1 and GluR2/3 in the rat cerebellum following pre- and perinatal delta9-tetrahydrocannabinol exposure
    Isabel Suarez
    Departamento Biología Celular y Genética, Universidad de Alcala, Madrid, Spain
    Cerebellum 3:66-74. 2004
    ....